Wolters Kluwer NV (PINKSHEETS:WTKWY) Conshohocken, PA (July 8, 2008) - Wolters Kluwer Health, a division of Wolters Kluwer, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, announced today the appointment of Susan Driscoll as Executive Vice President & General Manager of the Books division of its Professional & Education business unit.

Driscoll brings to Wolters Kluwer Health more than 25 years of experience in academic, trade and online publishing. Prior to Wolters Kluwer Health, Driscoll held the positions of Vice President, Strategy for Author Solutions, Inc., and President & CEO of iUniverse, Inc., the world's leader in online publishing. She successfully built the model for authors to find their customers utilizing state of the art publishing systems coupled with the marketing power of the internet.

"The appointment of Susan Driscoll brings us extensive electronic publishing experience as well as the C-level skills and business proficiency to take our leading books' and journals' content into the next era of new media", said Gordon Macomber, President & CEO of Wolters Kluwer Health, Professional & Education. "We could not be more thrilled to have Susan join our leadership team."

Driscoll gained extensive e-business experience while she served as Chief Operating Officer of Bedford, Freeman & Worth, guiding operations for the college text book publisher. She also held senior management roles at HarperCollins and Holt, Rinehart & Winston.

Jeff McCaulley, President & CEO of Wolters Kluwer Health continues: "I am excited about the leadership team within our Wolters Kluwer Health Professional & Education business unit, and our potential to accelerate growth and competitiveness as we strive to drive medical excellence via the transformation of healthcare through information."

Driscoll, who will be based in Philadelphia, PA, is a graduate of University of Notre Dame with a Bachelor of Fine Arts.

About Wolters Kluwer Health Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; electronic information providers, such as Ovid, Medi-Span® and ProVation®; and pharmaceutical information providers such as Adis International and Source®. Wolters Kluwer Health has annual revenues (2007) of $1,044 million (€761 million) and employs approximately 2,700 employees globally. For more information, visit www.WKHealth.com.

About Wolters Kluwer Wolters Kluwer is a leading global information services and publishing company. The company provides products and services globally for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer has annual revenues (2007) of €3.4 billion ($4.8 billion), maintains operations in over 33 countries across Europe, North America, and Asia Pacific and employs approximately 19,500 people worldwide. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

Forward-looking Statements This press release contains forward-looking statements. These statements may be identified by words such as "expect," "should," "could," "shall," and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.



Contact: Robert Dekker Kevin Entricken Director of Communications Vice President, Wolters Kluwer Health Investor Relations Wolters Kluwer NV +1 (610) 234-4533 + 31 (0)20 6070 407 robert.dekker@wolterskluwer.com ir@wolterskluwer.com



LINK: http://hugin.info/130682/R/1234430/262943.pdf

Wolters Kluwer NV

http://www.wolterskluwer.com

ISIN: NL0000395903

Stock Identifier: XAMS.WLSN

US: PINKSHEETS:WTKWY

ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 3) (Last 30 Days: 11) (Since Published: 615)